Skip to main content

Analyzing the Growth and Expansion of the Neurostimulation Devices Market

The global healthcare economic burden, at present, is primarily characterized by major contributors such as chronic pain and neurological disorders. The annual societal cost for chronic pain and neurological disorders accounted for $635 billion and $789 billion respectively in the U.S., in 2014. Opioids are one of the most preferred medicines for the treatment of chronic pain, however, the side-effects associated with opioids have resulted in a decline in their overall usage and sale.
Consequently, the increasing cases of neurological disorders and the need for a novel approach for the treatment of such diseases has led to the advent of neuromodulation technologies. The rapid shift of the healthcare industry toward neurostimulation devices from opioids and other conventional treatment techniques can be attributed to the efficient, safe, and targeted approach of neurostimulation devices.



BIS Research recently published a market intelligence report titled “Global Neurostimulation Devices Market- Analysis and Forecast (2019-2024),” projecting the expected growth of the neurostimulation devices market across the globe during the forecast period, 2019-2024. As per the published report, the market is anticipated to witness a compound annual growth rate of 9.23% during the forecast period and is expected to reach $11.97 billion by 2024.  
Neurostimulation devices can be either implantable or non-implantable. The various implantable neurostimulation devices include spinal cord stimulation, auditory brainstem implant, vagus nerve stimulation, sacral nerve stimulation, hypoglossal nerve stimulation, and deep brain stimulation devices. Based on the analysis of the market by BIS Research, the spinal cord stimulation segment dominated the neurostimulation devices market by acquiring the largest market share in 2017. Moreover, the auditory brainstem implant segment is anticipated to lead the market in terms of growth rate during the forecast period.
Further, under the application segment, the global neurostimulation devices market includes pain management, hearing loss, epilepsy, depression, Parkinson’s disease, and urinary and fecal incontinence. Amongst these, hearing loss application segment is expected to grow at the fastest CAGR, during the forecast period.
Product launches, and mergers and acquisitions are the most adopted strategies by players in the global neurostimulation devices market. Other strategies include joint ventures, partnerships, and collaborations. Some of the leading players functioning in the market are Cochlear Ltd., Abbott Laboratories, Neuronetics Inc., Mainstay Medical International plc, Nexeon MedSystems Inc., and Helius Medical Technology.

Comments

Post a Comment

Popular posts from this blog

Liquid Biopsy, North America, and Lung Cancer Occupying a Major Share in the Market

  Owing to the market availability of large number of liquid biopsy technologies, the liquid biopsy segment currently accounts for a dominating share in the global minimally invasive biopsy technologies market . However, the market growth in the segment can be attributed to the increasing demand for liquid biopsy and the strong product pipeline. For instance, CNI Second Opinion by Chronix Biomedical is presently under development and is expected to get launched during the forecast period 2019-2030. Owing to a widespread market presence of leading players and the huge prevalence of cancer, North America presently holds a major share in the global minimally invasive biopsy technologies market. According to the World Cancer Research Fund (WCRF), with an estimated 2 million cases in 2018, lung cancer is the most commonly occurring cancer in men and third-most commonly occurring cancer in women. Due to the widespread presence of cancer, the manufacturers including Biocept, Inc., Chron...
Post a Comment
Read more

Personal Care Ingredients Market Size, Share & Trends Analysis Report 2019-2029

The introduction and proliferation of bio-based ingredients in several industries, such as food and beverage, pharmaceuticals, and cosmetics, has been transforming the manufacturing landscape since 2000. Growing consumer inclination toward the adoption of bio-based products due to rising health and environmental concerns is driving the demand for bio-based ingredients in the cosmetics and personal care products. Besides, awareness among consumers regarding the harmful effects of synthetic ingredients chemicals has grown rapidly over the past years. In addition, the availability of green raw materials has also urged large cosmetic firms to develop bio-based cosmetic products. However, limited availability of raw material, due to erratic weather conditions and stringent environmental regulations, can pose substantial hurdles in the production of bio-based ingredients. Thus, leading companies have been focusing on developing new and sustainable ways of producing the ingredi...
Post a Comment
Read more

ADAS and Autonomous Driving Component Market

As per the recent BIS Research report, the ADAS and autonomous driving component market is segmented into component type, level of autonomy, vehicle type, and region for the purpose of study. These segments are further sub-segmented into various categories. In case of market by component type, it is sub-segmented into camera, radar, ultrasonic sensors, LiDAR, and ECU. The use of LiDAR is increasing rapidly in the market owing to reducing cost of LiDAR sensors and their greater range.
Post a Comment
Read more